出典: meddic


Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2012/07/23 19:47:30」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Distinguishing ischaemic optic neuropathy from optic neuritis by ganglion cell analysis.
  • Erlich-Malona N1, Mendoza-Santiesteban CE1,2,3, Hedges TR 3rd1, Patel N1, Monaco C1, Cole E1.
  • Acta ophthalmologica.Acta Ophthalmol.2016 Jul 1. doi: 10.1111/aos.13128. [Epub ahead of print]
  • PURPOSE: To determine whether a pattern of altitudinal ganglion cell loss, as detected and measured by optical coherence tomography (OCT), can be used to distinguish non-arteritic ischaemic optic neuropathy (NAION) from optic neuritis (ON) during the acute phase, and whether the rate or severity of
  • PMID 27364519
  • Musculoskeletal manifestations of Fabry disease: A retrospective study.
  • Lidove O1, Zeller V2, Chicheportiche V3, Meyssonnier V2, Sené T2, Godot S2, Ziza JM2.
  • Joint, bone, spine : revue du rhumatisme.Joint Bone Spine.2016 Jul;83(4):421-6. doi: 10.1016/j.jbspin.2015.11.001. Epub 2015 Dec 14.
  • OBJECTIVES: Fabry disease is a rare X-linked metabolic disorder characterized by a deficiency in the enzyme alpha-galactosidase A. Both males and females can be affected. The main presenting symptom is pain in the extremities, whereas at a more advanced stage, the manifestations include hypertrophic
  • PMID 26697993
  • The clinical spectrum of Caspr2 antibody-associated disease.
  • van Sonderen A1, Ariño H2, Petit-Pedrol M2, Leypoldt F2, Körtvélyessy P2, Wandinger KP2, Lancaster E2, Wirtz PW2, Schreurs MW2, Sillevis Smitt PA2, Graus F2, Dalmau J2, Titulaer MJ2.
  • Neurology.Neurology.2016 Jul 1. pii: 10.1212/WNL.0000000000002917. [Epub ahead of print]
  • OBJECTIVE: To report a large cohort of patients with antibodies against contactin-associated protein-like 2 (Caspr2) and provide the clinical spectrum of this disorder.METHODS: Serum and CSF samples were assessed at 2 neuroimmunology centers in Barcelona and Rotterdam. Patients were included if Casp
  • PMID 27371488



Dysautonomia (or autonomic dysfunction) is any disease or malfunction of the autonomic nervous system (ANS). The autonomic nervous system controls a number of functions in the body, such as heart rate, blood pressure, digestive ...
What is Dysautonomia? Dysautonomia is a general term used to describe a breakdown, or failure of the autonomic nervous system. The autonomic nervous system controls much of your involuntary functions. Symptoms are wide ...



リンク元自律神経障害」「自律神経失調」「disorders of the autonomic nervous system」「autonomic nervous system disease」「autonomic nervous system disorder
拡張検索familial dysautonomia」「acute pandysautonomia



autonomic neuropathyautonomic dysfunctiondysautonomiadisorders of the autonomic nervous system



autonomic imbalanceautonomic dystonia
[show details]

disorders of the autonomic nervous system」



autonomic dysfunctionautonomic nervous system diseaseautonomic nervous system disorderautonomic neuropathydysautonomiapure autonomic failure

autonomic nervous system disease」


autonomic nervous system disorderdisorders of the autonomic nervous systemdysautonomiapure autonomic failure

autonomic nervous system disorder」


autonomic nervous system diseasedisorders of the autonomic nervous systemdysautonomiapure autonomic failure

familial dysautonomia」



Riley-Day syndrome

acute pandysautonomia」


acute pandysautonomia APD